ChemoCentryx (CCXI) Upgraded by SVB Leerink LLC to Outperform

ChemoCentryx} stock has undergone multiple analysts rating changes in the recent past.  ChemoCentryx Upgraded by SVB Leerink LLC on 10-11-21. In a note to investors, the firm issued a new rating of Outperform. The analysts previously had rating of Market Perform.

View More ChemoCentryx (CCXI) Upgraded by SVB Leerink LLC to Outperform

ChemoCentryx (CCXI) Upgraded by JPMorgan Chase & Co. to Neutral

ChemoCentryx} stock has undergone multiple analysts rating changes in the recent past.  ChemoCentryx Upgraded by JPMorgan Chase & Co. on 10-11-21. In a note to investors, the firm issued a new rating of Neutral. The analysts previously had rating of Underweight.

View More ChemoCentryx (CCXI) Upgraded by JPMorgan Chase & Co. to Neutral

ChemoCentryx (NASDAQ:CCXI) Upgradedby SVBLeerinkLLC to Outperform

ChemoCentryx} stock has undergone multiple analysts rating changes in the recent past.  ChemoCentryx Upgradedby SVBLeerinkLLC on 10/11/2021. In a note to investors, the firm issued a new rating of Outperform. The analysts previously had rating of MarketPerform.

View More ChemoCentryx (NASDAQ:CCXI) Upgradedby SVBLeerinkLLC to Outperform